Santa Ana Bio is a precision immunology company leveraging multi-omics platforms and antibody engineering to deliver targeted therapies to patients with autoimmune and inflammatory diseases. Whole-section single cell profiling in Hidradenitis Suppurativainfo...
Santa Ana Bio has raised $176.02M over 3 rounds. Santa Ana Bio's latest funding round was a Series B for $125M on June 13, 2024. Date Round Amount Investors Valuation Revenue Sources 6/13/2024 Series B $125M Google Ventures, Access Biotechnology, Andreessen Horowitz, RTW Investments, TPG...
Santa Ana Bio是一家精准免疫学公司,专注于开发针对自身免疫性和炎症性疾病的靶向疗法。公司近日宣布完成了总计1.68亿美元的A轮和B轮融资。A轮融资由Versant Ventures领投,TPG的生命科学创新基金和GV参与;B轮融资由GV领投,Access Biotechnology、Andreessen Horowitz (a16z) Bio + Health和RTW等新老投资者共同参与。S...
Santa Ana Bio 查看官网 免疫治疗 医疗健康 医疗技术 所属公司:Santa Ana Bio, Inc. 当前融资轮次:B轮 成立日期:2021-01-01 所属地:加利福尼亚 简介:Santa Ana Bio是一家生物技术公司,开发一系列治疗药物,并利用其多组学平台来提高精准药物。它的平台,基于转录组学和蛋白质组学,解决了商业治疗的局限性。它...
6/13,受肿瘤 精准医疗 运动的启发,Santa Ana Bio 正在将该领域的细胞生物学方法应用于一个新的疾病领域——免疫学。这家 生物科技 公司于周四脱颖而出,获得了 1.68 亿美元的 A 轮和 B 轮融资,将三个项目——单克隆抗体 (mAb)、双特异性抗体和抗体-药物偶联物 (ADC)——
Santa Ana Bio是一家自身免疫疾病精准药物开发商。通过蛋白质组学、空间转录组学和基因组学等方法,公司建立了独特的SIERRA平台,用于精确表征疾病特异性亚群,快速开发全新自免机制和差异化临床管线。 北美洲-美国成立于: 2022-1公司规模: 10-50人运营中 投融资 提交融资需求 请登录 团队信息 暂未收录该公司团队...
Santa Ana Bio是一家自身免疫疾病精准药物开发商。通过蛋白质组学、空间转录组学和基因组学等方法,公司建立了独特的SIERRA平台,用于精确表征疾病特异性亚群,快速开发全新自免机制和差异化临床管线。近日,Santa Ana Bio宣布完成1.68亿美元融资。本轮融资由Google Ventures领投,现有投资者和新投资者共同参与,包括:Versant...
Koke Santa Ana: his birthday, what he did before fame, his family life, fun trivia facts, popularity rankings, and more.
Leonardo Santamaria Illustration Info The Queen's Gambit — view — Past Lives — view — The Dark Parts of the Universe — view — Netflix Earth Month: One World, Infinite Wonder — view — Scenes from a Marriage — view — “The Batman” Is a Waste of Robert Pattinson — view —...
Santa Ana also lies at the intersection between multiple economic, religious, and political projects that, taken together, greatly enhanced its position within the transnational religious map it helped create. Résumé La plupart des études concernant les questions de dimensionnement passent presque ...